Skip to Content
Still using that old version of Internet Explorer? This site will work much better in a newer version of IE or Firefox.
Download Internet Explorer 8 or Firefox 3 now!

Pre-Exposure Prophylaxis (PrEP) Phase I-II Trial for MSM intermittent vs. daily regimens

Principal Investigator(s): 
Eduard Sanders

Pre-Exposure Prophylaxis (PrEP) Phase I-II Trial with mostly men who have sex with men (MSM) in Mtwapa, Kenya, as part of a multi-centre placebo-controlled study (Nairobi, and Entebbe) offering intermittent vs. daily regimens supported by IAVI.